Peetz Christopher's Insider Trades & SAST Disclosures
Peetz Christopher's most recent trade in Mirum Pharmaceuticals Inc was a trade of 50,000 Performance Restricted Stock Units done . Disclosure was reported to the exchange on March 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peetz Christopher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 50,000 | 25,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 50,000 | 165,920 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.21 per share. | 15 Mar 2025 | 27,279 | 138,641 (0%) | 0% | 44.2 | 1,206,122 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 03 Mar 2025 | 40,000 | 155,920 (0%) | 0% | 2.9 | 117,440 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 40,000 | 238,487 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.19 per share. | 03 Mar 2025 | 20,608 | 115,920 (0%) | 0% | 47.2 | 972,492 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.61 per share. | 03 Mar 2025 | 19,392 | 136,528 (0%) | 0% | 46.6 | 903,861 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 48.22 per share. | 03 Feb 2025 | 9,102 | 115,920 (0%) | 0% | 48.2 | 438,921 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 12,500 | 25,000 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 12,500 | 131,859 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 23 Jan 2025 | 6,837 | 125,022 (0%) | 0% | 47.9 | 327,658 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 153,550 | 153,550 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 75,000 | 75,000 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 38,390 | 38,390 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 07 Jan 2025 | 7,489 | 119,359 (0%) | 0% | 42.8 | 320,644 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 08 Nov 2024 | 65 | 126,848 (0%) | 0% | 21.0 | 1,368 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 34,013 | 278,487 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 23 Jul 2024 | 34,013 | 126,783 (0%) | 0% | 2.9 | 99,862 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 1,900 | 0 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 10 May 2024 | 817 | 92,770 (0%) | 0% | 21.0 | 17,195 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 02 Feb 2024 | 6,013 | 104,112 (0%) | 0% | 26.2 | 157,491 | Common Stock |
| Mirum Pharmaceuticals Inc | Peetz Christopher | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Peetz Christopher | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 08 Jan 2024 | 5,209 | 110,125 (0%) | 0% | 28.0 | 146,033 | Common Stock |
| Alpine Immune Sciences Inc | Peetz Christopher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 17,500 | 17,500 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.65 per share. | 03 Jul 2023 | 5,498 | 115,334 (0%) | 0% | 25.6 | 141,005 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 16.92 per share. | 10 May 2023 | 1,256 | 120,832 (0%) | 0% | 16.9 | 21,256 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 50,000 | 119,576 (0%) | 0% | 0 | Common Stock | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 09 Jan 2023 | 5,159 | 91,953 (0%) | 0% | 20.6 | 106,390 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 17.04 per share. | 10 Nov 2022 | 49 | 69,576 (0%) | 0% | 17.0 | 835 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 13.57 per share. | 10 May 2022 | 1,500 | 69,527 (0%) | 0% | 13.6 | 20,349 | Common STock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 40,000 | 68,027 (0%) | 0% | 0 | Common Stock | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 14.40 per share. | 24 Nov 2021 | 7,000 | 28,027 (0%) | 0% | 14.4 | 100,800 | Common Stock |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Purchase of securities on an exchange or from another person at price $ 10.17 per share. | 23 Sep 2021 | 1,900 | 1,900 (0%) | 0% | 10.2 | 19,323 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 14.62 per share. | 10 May 2021 | 1,453 | 2,824 (0%) | 0% | 14.6 | 21,243 | Common STock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Alpine Immune Sciences Inc | Christopher Peetz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 7,650 | 7,650 | - | - | Stock Option (Right to buy) | |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.76 per share. | 23 Dec 2020 | 3,000 | 199,570 (0%) | 0% | 18.8 | 56,280 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 18.60 per share. | 23 Dec 2020 | 2,000 | 201,570 (0%) | 0% | 18.6 | 37,200 | Common Stock |
| Mirum Pharmaceuticals Inc | Christopher Peetz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 15.27 per share. | 10 Nov 2020 | 1,371 | 1,371 (0%) | 0% | 15.3 | 20,930 | Common STock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges